$410 Million is the total value of Eagle Health Investments LP's 28 reported holdings in Q4 2021. The portfolio turnover from Q3 2021 to Q4 2021 was 11.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
HUM | Buy | HUMANA INC | $36,469,000 | +36.8% | 78,621 | +14.7% | 8.88% | +5.1% |
AZN | Buy | ASTRAZENECA PLCsponsored adr | $35,629,000 | +32.0% | 611,665 | +36.1% | 8.68% | +1.4% |
UTHR | Buy | UNITED THERAPEUTICS CORP DEL | $33,155,000 | +83.2% | 153,438 | +56.5% | 8.08% | +40.8% |
IQV | Buy | IQVIA HLDGS INC | $28,095,000 | +44.5% | 99,577 | +22.7% | 6.84% | +11.0% |
ARGX | Buy | ARGENX SEsponsored adr | $21,828,000 | +34.8% | 62,332 | +16.2% | 5.32% | +3.5% |
ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $21,066,000 | +40.4% | 750,760 | +70.1% | 5.13% | +7.8% |
BPMC | Buy | BLUEPRINT MEDICINES CORP | $20,634,000 | +13.9% | 192,639 | +9.3% | 5.03% | -12.5% |
NTRA | Buy | NATERA INC | $19,770,000 | +7.9% | 211,694 | +28.7% | 4.82% | -17.1% |
ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $19,282,000 | +13.3% | 113,702 | +26.2% | 4.70% | -12.9% |
VRTX | Buy | VERTEX PHARMACEUTICALS INC | $18,039,000 | +236.6% | 82,144 | +178.0% | 4.40% | +158.5% |
INSP | Buy | INSPIRE MED SYS INC | $17,543,000 | +9.7% | 76,253 | +11.1% | 4.27% | -15.7% |
CANO | Buy | CANO HEALTH INC | $17,355,000 | +102.3% | 1,947,779 | +188.0% | 4.23% | +55.4% |
OM | Sell | OUTSET MED INC | $15,164,000 | -7.8% | 329,000 | -1.1% | 3.70% | -29.2% |
AXNX | Buy | AXONICS INC | $14,362,000 | +15.9% | 256,465 | +34.7% | 3.50% | -11.0% |
DXCM | Sell | DEXCOM INC | $14,337,000 | -11.1% | 26,700 | -9.5% | 3.49% | -31.7% |
AGIO | Buy | AGIOS PHARMACEUTICALS INC | $14,181,000 | +30.5% | 431,413 | +83.2% | 3.46% | +0.2% |
AMWL | Buy | AMERICAN WELL CORPcl a | $13,577,000 | +65.4% | 2,247,908 | +149.4% | 3.31% | +27.0% |
SGEN | New | SEAGEN INC | $12,445,000 | – | 80,500 | +100.0% | 3.03% | – |
GH | Buy | GUARDANT HEALTH INC | $11,938,000 | -0.2% | 119,360 | +24.8% | 2.91% | -23.3% |
MRTX | MIRATI THERAPEUTICS INC | $7,628,000 | -17.1% | 52,000 | 0.0% | 1.86% | -36.3% | |
CMAX | Buy | CAREMAX INC | $5,489,000 | -7.9% | 714,755 | +15.9% | 1.34% | -29.3% |
FDMT | Buy | 4D MOLECULAR THERAPEUTICS IN | $2,898,000 | +88.2% | 132,090 | +131.4% | 0.71% | +44.7% |
KYMR | KYMERA THERAPEUTICS INC | $2,349,000 | +8.1% | 37,000 | 0.0% | 0.57% | -17.0% | |
BEAM | New | BEAM THERAPEUTICS INC | $2,303,000 | – | 28,900 | +100.0% | 0.56% | – |
ARVN | ARVINAS INC | $1,889,000 | -0.1% | 23,000 | 0.0% | 0.46% | -23.2% | |
CCCC | C4 THERAPEUTICS INC | $1,520,000 | -27.9% | 47,200 | 0.0% | 0.37% | -44.7% | |
LYEL | LYELL IMMUNOPHARMA INC | $774,000 | -47.7% | 100,000 | 0.0% | 0.19% | -59.7% | |
OLK | OLINK HLDG ABsponsored ads | $728,000 | -24.9% | 40,000 | 0.0% | 0.18% | -42.5% | |
DRNA | Exit | DICERNA PHARMACEUTICALS INC | $0 | – | -406,525 | -100.0% | -2.60% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-02-10
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
IQVIA HLDGS INC | 12 | Q3 2023 | 9.6% |
UNITED THERAPEUTICS CORP DEL | 12 | Q3 2023 | 8.7% |
ALNYLAM PHARMACEUTICALS INC | 12 | Q3 2023 | 8.5% |
NATERA INC | 12 | Q3 2023 | 8.5% |
ARGENX SE | 12 | Q3 2023 | 7.0% |
DEXCOM INC | 12 | Q3 2023 | 5.7% |
OUTSET MED INC | 12 | Q3 2023 | 7.3% |
AGIOS PHARMACEUTICALS INC | 12 | Q3 2023 | 7.2% |
ADAPTIVE BIOTECHNOLOGIES COR | 12 | Q3 2023 | 5.1% |
GUARDANT HEALTH INC | 12 | Q3 2023 | 3.8% |
View Eagle Health Investments LP's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-12 |
13F-HR | 2023-10-27 |
13F-HR | 2023-08-14 |
13F-HR | 2023-05-12 |
13F-HR | 2023-02-13 |
13F-HR | 2022-11-14 |
13F-HR | 2022-08-11 |
13F-HR | 2022-05-12 |
13F-HR | 2022-02-10 |
13F-HR | 2021-10-20 |
View Eagle Health Investments LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.